Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Ramazi S et al. | 2023 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and HFF cells (human foreskin fibroblast cells) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Mercado-Sáenz S et al. | 2023 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>)/WS8105-1C | magnetic field, signals/pulses, 50/60 Hz, co-exposure, also other exposures without EMF | - |
Lazzarini R et al. | 2023 | intact cell/cell culture, MDA-MB-231 cells (breast cancer cell line) and MDA-MB-231 (human breast cell line) | magnetic field, 50/60 Hz | - |
Alipour M et al. | 2022 | intact cell/cell culture, rat bone marrow-derived mesenchymal cells (BMSCs) | static magnetic field, magnetic field, 50/60 Hz, co-exposure | - |
Ambalayam S et al. | 2022 | animal, rat/Wistar | magnetic field, 50/60 Hz, low frequency | - |
Choi JH et al. | 2022 | intact cell/cell culture, human hair bulb spheroid and hair follicle cultures | magnetic field, 50/60 Hz | - |
Aparicio-Bautista DI et al. | 2022 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, low frequency | - |
Masoudi-Khoram N et al. | 2022 | intact cell/cell culture, MCF-7 and MDA-MB-231 (human breast cancer cell lines) | magnetic field, low frequency, 50/60 Hz | - |
Cios A et al. | 2021 | intact cell/cell culture, HEK293 (kidney cells), 786-O, 769-P, and Caki1 (clear cell renal carcinoma cell lines) | magnetic field, 50/60 Hz | 4.5 mT |
Kayhan H et al. | 2020 | intact cell/cell culture, human, neonatal, healthy primary dermal fibroblast and MCF7 cells (human metastatic breast cancer cells) | magnetic field, 50/60 Hz, low frequency | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.